Facebook
Twitter
LinkedIn
Forward- Physicians
- Nurse Practitioners
- Physician Assistants
- Nurse
- Research Staff
Participants who engage in this educational intervention will be able to:
- Assess patients diagnosed with hematologic malignancies, their underlying biology and risk stratification, treatment plan, predicted results.
- Interpret new therapies, clinical trials and diagnostic dilemmas for pediatric patients being treated with leukemia and/or lymphoma.
- Review biology, molecular and cytogenetic findings, flow cytometry and morphology
The following persons in control of content disclosed the following financial relationships which were reviewed via the MCW conflict of interest mitigation process and addressed.
| Name | Company | Role |
|---|---|---|
| Rachel Phelan | Bluebird Bio | Advisory Board Participant |
Contact
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Medical College of Wisconsin designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Medical College of Wisconsin designates this activity for up to 1.00 hours of participation for continuing education for allied health professionals.
Successful completion of this CME activity, which includes participation in the activity and individual assessment of and feedback to the learner, enables the learner to earn up to 1 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.
Participation shared with ABP through PARS:
Individual participants’ information will be shared with ABP through the ACCME Program and Activity Reporting System (PARS).